2026-01-24 - Analysis Report
**Estée Lauder Companies (EL) Analysis Report**
=====================================================

**Company Overview**
--------------------

Estée Lauder Companies is a multinational cosmetics company.

**Return Rate Comparison**
-------------------------

### Ticker: EL

* Cumulative Return: -5.26%
* S&P 500 (VOO): 126.41%
* Divergence: -131.70, Relative Divergence: 11.10%

### Alpha, Beta Analysis
| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 30.0% | 19.8% | 18.0% | 0.8 | 46.9B |
| 2017-2019  | 92.0% | 19.8% | 67.0% | 0.9 | 74.4B |
| 2018-2020  | 72.0% | 32.6% | 47.0% | 0.9 | 95.9B |
| 2019-2021  | 143.0% | 32.6% | 77.0% | 1.0 | 133.4B |
| 2020-2022  | 1.0% | 44.9% | -6.0% | 1.1 | 89.4B |
| 2021-2023  | -91.0% | 66.0% | -112.0% | 1.3 | 52.7B |
| 2022-2024  | -176.0% | 72.1% | -205.0% | 1.3 | 27.0B |
| 2023-2025  | -110.0% | 74.6% | -185.0% | 1.3 | 37.7B |

**Stock Price Fluctuations**
---------------------------

* Close: $117.69
* 5-day SMA: $116.91
* 20-day SMA: $111.53
* 60-day SMA: $101.75
* Last-Market: -$1.51 (down)

**RSI and PPO Index Indicators**
--------------------------------

* Market Risk Indicator (MRI): 0.70 (Medium)
* RSI: 69.94
* PPO: 0.24
* Hybrid Signal: Buy (Cash 0%)

**Recent News & Significant Events**
------------------------------------

Based on Yahoo Finance:

* Is The Estee Lauder Companies (EL) Outperforming Other Consumer Staples Stocks This Year? (2026-01-22)
* Estee Lauder Companies (NYSE:EL) Stock Price Expected to Rise, TD Cowen Analyst Says (2026-01-21)
* ... (other recent news)

**Analyst Opinions**
---------------------

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.42 (~Buy)
- Opinions: 24
- Target Price (avg/high/low): 109.58 / 131.00 / 65.00

**Recent Earnings Analysis**
-----------------------------

| Date | EPS | Revenue |
|-----|-----|---------|
| 2025-10-30 | 0.13 | $3.48B  |
| 2025-05-01 | 0.44 | $3.55B  |
| 2025-02-04 | -1.64 | $4.00B  |
| 2024-10-31 | -0.43 | $3.36B  |

**Financial Information**
-------------------------

### Revenue and Profitability

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $3.48B | 73.37% |
| 2025-06-30 | $3.41B | 72.00% |
| 2025-03-31 | $3.55B | 74.96% |
| 2024-12-31 | $4.00B | 76.10% |
| 2024-09-30 | $3.36B | 72.39% |

### Capital and Profitability

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $3.89B | 1.21% |
| 2025-06-30 | $3.87B | -14.13% |
| 2025-03-31 | $4.34B | 3.66% |
| 2024-12-31 | $4.17B | -14.15% |
| 2024-09-30 | $5.08B | -3.07% |

**Comprehensive Analysis**
---------------------------

Based on the analysis above, the stock's performance has been mixed in recent years, with a significant decline in 2023-2025. The stock's RSI and PPO indices suggest a medium-risk investment. The company's financial information shows a fluctuating revenue and profitability. The analyst opinions are generally positive, with a mean rating of 2.42 (~Buy) and a target price of $109.58. However, the expected return is negative at -579.60%. Overall, the stock's performance is uncertain, and investors should carefully consider the risks and opportunities before making a decision.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.